EUCTR2004-002273-24-IT进行中（未招募）不适用
A phase 2 trial of CHOP chemotherapy followed by Zevalin for untreated elderly diffuse large b-cell lymphoma DLBCL patients
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点目标入组 20 人开始时间: 2006年4月21日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Parallel Randomised Phase II Trial of CHOP Chemotherapy With or Without Bortezomib in Relapsed Mantle Cell Lymphoma - Bortezomib StudyRelapsed, or refractory mantle cell lymphomaMedDRA version: 20.0 Level: PT Classification code 10026800 Term: Mantle cell lymphoma recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2006-006090-24-GBPlymouth Hospitals NHS Trust46
已完成
2 期
Phase II trial of perioperative chemotherapy with cisplatin and dose dense paclitaxel in patients with stage IB2,IIA2 orIIB uterine cervical cancer SGSG014Cervical cancer patients with clinical stage IB2, IIA, IIBJPRN-UMIN000009643Sankai Gynecology Study Group50
已完成
不适用
Phase II trial of perioperative chemotherapy with cisplatin and dose dense paclitaxel in patients with stage Ib2-IIb uterine cervical cancer (SGSG013)JPRN-UMIN000006440Sankai Gynecology Study Group50
尚未招募
不适用
A phase II trial of preoperative chemotherapy with capecitabine plus short-course radiotherapy for resectable T3 rectal cancerJPRN-UMIN000016518Meiwa Hospital60
招募中
2 期
Phase II study of combination chemotherapy using paclitaxel, carboplatin, and bevacizumab in patients with advanced or recurrent cervical cancer.cervical cancerJPRN-UMIN000024137Hyogo Cancer Center30